Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine

M. Joerger*, J. A. Burgers, P. Baas, V. D. Doodeman, P. H.M. Smits, R. S. Jansen, L. D. Vainchtein, H. Rosing, A. D.R. Huitema, J. H. Beijnen, J. H.M. Schellens

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

18 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology